Syndex Bio develops mcPCR, a proprietary methyl‑copying PCR technology that preserves DNA methylatio Sign up to read more
Profile updated Jun 2026
No filings found for this company.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| SYNDEX BIO INCCORP | ORDINARY | 10,857,260 | 100.0% |
Companies with the most similar business descriptions.
Accounts not filed